生物标志物 生物标志物
Meina Quan1,2,3,4, Yazhen Huang1, Bote Zhao1
1Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, Beijing, China.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
血炎症生物标志物,包括中性粒细胞与淋巴细胞比率 (NLR),有助于诊断阿尔茨海默氏症痴呆症 (ADD) 并将其与其他神经退行性疾病区分开来. 这些标记物与大脑脊髓液 (CSF) 与阿尔茨海默病生物标记物相关.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
背景情况:
- 阿尔茨海默病痴呆症 (ADD) 诊断可能具有挑战性,特别是将其与其他神经退行性疾病区分开来.
- 脑脊液 (CSF) 生物标志物已经确立,但具有侵入性;探索基于血的标志物至关重要.
研究的目的:
- 调查ADD和其他神经退行性痴呆症 (非ADD) 的血炎症生物标志物.
- 评估血炎症标志物和CSF阿尔茨海默氏病生物标志物之间的关联.
- 评估ADD等离子体炎症标志物的诊断和差异诊断值.
主要方法:
- 分析了来自两个队列的245名和328名参与者,包括对照组,ADD和非ADD组.
- 测量CSF生物标志物 (Aβ42,ptau181,ttau) 和血炎症标志物 (中性细胞,淋巴细胞,血小板计数,CRP,白蛋白).
- 统计分析以确定预测性能和相关性.
主要成果:
- 脑液生物标志物比率,炎症比率和ApoE4的组合有效地将ADD与对照区分开来.
- 一个特定的组合,包括CSF比率,中性粒细胞与淋巴细胞比率 (NLR),血小板与淋巴细胞比率 (PLR) 和ApoE4,将ADD与NonADD区分开来.
- 血炎症标志物,特别是NLR,在ADD患者中与CSFAD生物标志物呈正相关性.
结论:
- 血炎症生物标志物为ADD的诊断提供了显著的附加值.
- 这些标记物在ADD与其他神经退行性疾病的差异诊断中也很有价值.
- 作为与AD病理学相关的可访问指标,NLR和PLR显示出希望.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516


